Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMGN

ImmunoGen (IMGN)

ImmunoGen Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMGN
DateTimeSourceHeadlineSymbolCompany
11/26/20183:18PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/26/20183:01PMBusiness WireImmunoGen Announces Resignation of Chief Financial OfficerNASDAQ:IMGNImmunoGen Inc
11/07/20188:55AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
11/06/20183:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
11/02/201810:47AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
11/02/20185:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
11/02/20185:30AMBusiness WireImmunoGen Reports Recent Progress and Third Quarter 2018 Operating ResultsNASDAQ:IMGNImmunoGen Inc
11/01/20188:01AMBusiness WireImmunoGen to Present New Data on Novel Antibody-Drug Conjugates at 60th ASH Annual MeetingNASDAQ:IMGNImmunoGen Inc
10/20/20185:30AMBusiness WireImmunoGen Presents Initial Data from FORWARD II Expansion Cohort Assessing Mirvetuximab Soravtansine in Combination with KEYT...NASDAQ:IMGNImmunoGen Inc
10/18/20183:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Third Quarter 2018 Operating ResultsNASDAQ:IMGNImmunoGen Inc
10/17/20188:53AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/08/20185:05PMBusiness WireImmunoGen to Present Initial Data from FORWARD II Expansion Cohort of Mirvetuximab Soravtansine in Combination with KEYTRUDA ...NASDAQ:IMGNImmunoGen Inc
10/01/20182:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
10/01/20182:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
09/25/20181:44PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:IMGNImmunoGen Inc
09/24/20183:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
09/20/20184:05PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IMGNImmunoGen Inc
09/11/20184:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
08/27/20183:30PMBusiness WireImmunoGen Announces Webcasts of Presentations at Upcoming ConferencesNASDAQ:IMGNImmunoGen Inc
08/03/201810:32AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMGNImmunoGen Inc
07/31/20183:30PMBusiness WireImmunoGen Announces Webcast of Presentation at the Canaccord Genuity Growth ConferenceNASDAQ:IMGNImmunoGen Inc
07/27/20185:37AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
07/27/20185:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2018 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/12/20183:30PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2018 Operating ResultsNASDAQ:IMGNImmunoGen Inc
07/02/201810:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
07/02/201810:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
06/28/20183:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
06/25/201810:11AMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:IMGNImmunoGen Inc
06/25/201810:05AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IMGNImmunoGen Inc
06/22/20183:04PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
 Showing the most relevant articles for your search:NASDAQ:IMGN